Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CCEP.AS Stock Summary
Top 10 Correlated ETFs
CCEP.AS
In the News
CCEP.AS Financial details
Company Rating
Strong Buy
Market Cap
30.33B
Income
2.87B
Revenue
31.08B
Book val./share
17.38
Cash/share
4.33
Dividend
1.84
Dividend %
3.08%
Employees
32K
Optionable
No
Shortable
Yes
Earnings
08 Aug 2024
P/E
18.12
Forward P/E
15.52
PEG
2.02
P/S
1.58
P/B
3.67
P/C
15.13
P/FCF
11.78
Quick Ratio
0.64
Current Ratio
0.89
Debt / Equity
1.36
LT Debt / Equity
1.2
-
-
EPS (TTM)
6.26
EPS next Y
4.22
EPS next Q
-
EPS this Y
7.88%
EPS next Y
-32.51%
EPS next 5Y
-12.7%
EPS last 5Y
8.75%
Revenue last 5Y
8.33%
Revenue Q/Q
2.75%
EPS Q/Q
-5.95%
-
-
-
-
SMA20
3.13%
SMA50
8.2%
SMA100
17.86%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
21%
ROC
0.09%
Gross Margin
36%
Oper. Margin
12%
Profit Margin
9%
Payout
51%
Shs Outstand
458.85M
Shs Float
204.58M
-
-
-
-
Target Price
-
52W Range
52.15-66.7
52W High
-0.76%
52W Low
+25.96%
RSI
57
Rel Volume
0.68
Avg Volume
21.19K
Volume
14.47K
Perf Week
0.15%
Perf Month
5.48%
Perf Quarter
19.96%
Perf Half Y
9.17%
-
-
-
-
Beta
0.709
-
-
Volatility
0.41%, 1.23%
Prev Close
-1.06%
Price
65.5
Change
-1.5%
CCEP.AS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 25.8 | 23.31 | 30.18 | 37.9 | 39.06 | |
Net income per share | 2.34 | 1.09 | 2.15 | 3.3 | 3.64 | |
Operating cash flow per share | 4.09 | 3.27 | 4.64 | 6.42 | 5.72 | |
Free cash flow per share | 2.8 | 2.38 | 3.66 | 5.1 | 3.99 | |
Cash per share | 0.68 | 3.35 | 3.21 | 3.6 | 4.33 | |
Book value per share | 13.22 | 13.24 | 15.42 | 16.3 | 17.39 | |
Tangible book value per share | -10.46 | -10.78 | -22.04 | -21.13 | -19.46 | |
Share holders equity per share | 13.22 | 13.24 | 15.42 | 16.3 | 17.39 | |
Interest debt per share | 14.1 | 16.11 | 29.19 | 26.45 | 23.98 | |
Market cap | 20.8B | 17.95B | 22.38B | 23.51B | 27.86B | |
Enterprise value | 26.9B | 23.61B | 34.11B | 34.03B | 37.85B | |
P/E ratio | 19.08 | 36.04 | 22.79 | 15.59 | 16.69 | |
Price to sales ratio | 1.73 | 1.69 | 1.63 | 1.36 | 1.55 | |
POCF ratio | 10.92 | 12.05 | 10.57 | 8.02 | 10.61 | |
PFCF ratio | 15.97 | 16.59 | 13.39 | 10.09 | 15.21 | |
P/B Ratio | 3.38 | 2.98 | 3.18 | 3.16 | 3.49 | |
PTB ratio | 3.38 | 2.98 | 3.18 | 3.16 | 3.49 | |
EV to sales | 2.24 | 2.23 | 2.48 | 1.96 | 2.11 | |
Enterprise value over EBITDA | 12.02 | 15.08 | 14.6 | 11.52 | 12.34 | |
EV to operating cash flow | 14.13 | 15.85 | 16.11 | 11.61 | 14.41 | |
EV to free cash flow | 20.66 | 21.82 | 20.42 | 14.61 | 20.66 | |
Earnings yield | 0.05 | 0.03 | 0.04 | 0.06 | 0.06 | |
Free cash flow yield | 0.06 | 0.06 | 0.07 | 0.1 | 0.07 | |
Debt to equity | 1.04 | 1.19 | 1.87 | 1.6 | 1.36 | |
Debt to assets | 0.34 | 0.37 | 0.45 | 0.41 | 0.37 | |
Net debt to EBITDA | 2.73 | 3.62 | 5.02 | 3.56 | 3.26 | |
Current ratio | 0.75 | 0.98 | 0.95 | 0.89 | 0.91 | |
Interest coverage | 10.68 | 5.65 | 8.81 | 11.52 | 16.12 | |
Income quality | 1.31 | 2.14 | 1.53 | 1.5 | 1.61 | |
Dividend Yield | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | |
Payout ratio | 0.53 | 0.78 | 0.65 | 0.51 | 0.49 | |
Sales general and administrative to revenue | 0.07 | 0.09 | 0.08 | 0.07 | 0.02 | |
Research and developement to revenue | 0 | 0.01 | 0.01 | 0 | 0 | |
Intangibles to total assets | 0.59 | 0.57 | 0.59 | 0.58 | 0.58 | |
Capex to operating cash flow | -0.32 | -0.27 | -0.21 | -0.21 | -0.3 | |
Capex to revenue | -0.05 | -0.04 | -0.03 | -0.03 | -0.04 | |
Capex to depreciation | -0.94 | -0.56 | -0.57 | -0.74 | -1.03 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 26.38 | 18.06 | 27.34 | 34.79 | 37.72 | |
ROIC | 0.09 | 0.04 | 0.05 | 0.08 | 0.09 | |
Return on tangible assets | 0.14 | 0.06 | 0.08 | 0.12 | 0.13 | |
Graham Net | -22.54 | -22.23 | -38.79 | -37.75 | -35.76 | |
Working capital | -1.01B | -64M | -333M | -770M | -673.55M | |
Tangible asset value | -4.87B | -4.91B | -10.05B | -9.66B | -8.93B | |
Net current asset value | -9.43B | -9.14B | -16.12B | -15.32B | -14.69B | |
Invested capital | 1.04 | 1.19 | 1.87 | 1.6 | 1.36 | |
Average receivables | 1.8B | 1.73B | 2.26B | 2.95B | 3B | |
Average payables | 2.81B | 2.77B | 3.5B | 4.64B | 3.68B | |
Average inventory | 708M | 702M | 919M | 1.27B | 1.37B | |
Days sales outstanding | 54.82 | 56.72 | 76.03 | 64.09 | 60.09 | |
Days payables outstanding | 136.92 | 146.3 | 178.23 | 166.18 | 73.32 | |
Days of inventory on hand | 35.55 | 36.18 | 48.67 | 45.39 | 43.12 | |
Receivables turnover | 6.66 | 6.44 | 4.8 | 5.7 | 6.07 | |
Payables turnover | 2.67 | 2.49 | 2.05 | 2.2 | 4.98 | |
Inventory turnover | 10.27 | 10.09 | 7.5 | 8.04 | 8.47 | |
ROE | 0.18 | 0.08 | 0.14 | 0.2 | 0.21 | |
Capex per share | -1.29 | -0.9 | -0.98 | -1.32 | -1.73 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 9.84 | 18.73 | 9.78 | 19.42 | 19.9 | |
Net income per share | 0.92 | 1.74 | 0.93 | 1.85 | 1.74 | |
Operating cash flow per share | 1.39 | 2.33 | 1.42 | 2.64 | 3.12 | |
Free cash flow per share | 1.04 | 1.53 | 1.14 | 1.98 | 2.04 | |
Cash per share | 3.58 | 3.6 | 4.3 | 4.31 | 4.33 | |
Book value per share | 16.2 | 16.3 | 16.9 | 16.94 | 17.38 | |
Tangible book value per share | -21.02 | -21.13 | -19.69 | -19.74 | -19.45 | |
Share holders equity per share | 16.2 | 16.3 | 16.9 | 16.94 | 17.38 | |
Interest debt per share | 22.21 | 26.24 | 19.68 | 25.87 | 23.85 | |
Market cap | 20.36B | 23.51B | 24.98B | 27.02B | 27.87B | |
Enterprise value | 18.97B | 34.03B | 23.87B | 37.67B | 37.86B | |
P/E ratio | 12.1 | 7.38 | 14.62 | 7.98 | 8.72 | |
Price to sales ratio | 4.5 | 2.75 | 5.56 | 3.04 | 3.05 | |
POCF ratio | 31.84 | 22.06 | 38.22 | 22.38 | 19.43 | |
PFCF ratio | 42.55 | 33.64 | 47.89 | 29.81 | 29.76 | |
P/B Ratio | 2.73 | 3.16 | 3.22 | 3.48 | 3.49 | |
PTB ratio | 2.73 | 3.16 | 3.22 | 3.48 | 3.49 | |
EV to sales | 4.2 | 3.98 | 5.32 | 4.24 | 4.14 | |
Enterprise value over EBITDA | 28.61 | 23.9 | 30.73 | 24.72 | 24.54 | |
EV to operating cash flow | 29.67 | 31.93 | 36.52 | 31.19 | 26.38 | |
EV to free cash flow | 39.65 | 48.69 | 45.76 | 41.55 | 40.41 | |
Earnings yield | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | |
Free cash flow yield | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | |
Debt to equity | 1.37 | 1.6 | 1.16 | 1.52 | 1.36 | |
Debt to assets | 0.35 | 0.41 | 0.3 | 0.39 | 0.37 | |
Net debt to EBITDA | -2.09 | 7.39 | -1.43 | 6.99 | 6.47 | |
Current ratio | 0.89 | 0.89 | 0.85 | 0.85 | 0.91 | |
Interest coverage | 0 | 12.2 | 0 | 12.35 | 12.74 | |
Income quality | 1.52 | 1.34 | 1.53 | 1.43 | 1.8 | |
Dividend Yield | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | |
Payout ratio | 0.6 | 0.58 | 0.36 | 0.36 | 0.65 | |
Sales general and administrative to revenue | 0.03 | 0.02 | 0.07 | 0.04 | 0 | |
Research and developement to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.58 | 0.58 | 0.56 | 0.56 | 0.58 | |
Capex to operating cash flow | -0.25 | -0.34 | -0.2 | -0.25 | -0.35 | |
Capex to revenue | -0.04 | -0.04 | -0.03 | -0.03 | -0.05 | |
Capex to depreciation | -1.06 | -0.9 | -0.7 | -0.81 | -1.22 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 18.27 | 25.27 | 18.81 | 26.54 | 26.08 | |
ROIC | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | |
Return on tangible assets | 0.03 | 0.07 | 0.03 | 0.07 | 0.06 | |
Graham Net | -38.1 | -37.75 | -36.9 | -36.44 | -35.75 | |
Working capital | -770M | -770M | -1.31B | -1.31B | -673.55M | |
Tangible asset value | -9.66B | -9.66B | -9.04B | -9.04B | -8.93B | |
Net current asset value | -15.32B | -15.32B | -14.58B | -14.58B | -14.69B | |
Invested capital | 1.37 | 1.6 | 1.16 | 1.52 | 1.36 | |
Average receivables | 2.97B | 2.87B | 3.03B | 3.19B | 0 | |
Average payables | 3.89B | 3.88B | 5.45B | 5.66B | 0 | |
Average inventory | 1.4B | 1.38B | 1.55B | 1.71B | 0 | |
Days sales outstanding | 53.78 | 31.98 | 60.51 | 33.95 | 29.07 | |
Days payables outstanding | 83.98 | 81.98 | 184.67 | 86.32 | 80.62 | |
Days of inventory on hand | 42.83 | 22.39 | 54.12 | 27.02 | 20.89 | |
Receivables turnover | 1.67 | 2.81 | 1.49 | 2.65 | 3.1 | |
Payables turnover | 1.07 | 1.1 | 0.49 | 1.04 | 1.12 | |
Inventory turnover | 2.1 | 4.02 | 1.66 | 3.33 | 4.31 | |
ROE | 0.06 | 0.11 | 0.06 | 0.11 | 0.1 | |
Capex per share | -0.35 | -0.8 | -0.29 | -0.66 | -1.08 |
CCEP.AS Frequently Asked Questions
What is Coca-Cola Europacific Partners PLC stock symbol ?
Coca-Cola Europacific Partners PLC is a GB stock and trading under the symbol CCEP.AS
What is Coca-Cola Europacific Partners PLC stock quote today ?
Coca-Cola Europacific Partners PLC stock price is $65.5 today.
Is Coca-Cola Europacific Partners PLC stock public?
Yes, Coca-Cola Europacific Partners PLC is a publicly traded company.